β-1,3-Gal-TL Polyclonal Antibody

    • Catalog No.:YT5005
    • Applications:WB;IHC;IF;ELISA
    • Reactivity:Human;Mouse
      • Target:
      • β-1,3-Gal-TL
      • Fields:
      • >>Other types of O-glycan biosynthesis
      • Gene Name:
      • B3GALTL
      • Protein Name:
      • Beta-1,3-glucosyltransferase
      • Human Swiss Prot No:
      • Q6Y288
      • Mouse Swiss Prot No:
      • Q8BHT6
      • Immunogen:
      • The antiserum was produced against synthesized peptide derived from human B3GALTL. AA range:449-498
      • Specificity:
      • β-1,3-Gal-TL Polyclonal Antibody detects endogenous levels of β-1,3-Gal-TL protein.
      • Formulation:
      • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
      • Source:
      • Polyclonal, Rabbit,IgG
      • Dilution:
      • WB 1:500 - 1:2000. IHC 1:100 - 1:300. ELISA: 1:40000.. IF 1:50-200
      • Purification:
      • The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
      • Concentration:
      • 1 mg/ml
      • Storage Stability:
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • Other Name:
      • B3GALTL;B3GTL;Beta-1;3-glucosyltransferase;Beta3Glc-T;Beta-3-glycosyltransferase-like
      • Observed Band(KD):
      • 57kD
      • Background:
      • The protein encoded by this gene is a beta-1,3-glucosyltransferase that transfers glucose to O-linked fucosylglycans on thrombospondin type-1 repeats (TSRs) of several proteins. The encoded protein is a type II membrane protein. Defects in this gene are a cause of Peters-plus syndrome (PPS).[provided by RefSeq, Mar 2009],
      • Function:
      • disease:Defects in B3GALTL are the cause of Peters-plus syndrome (PPS) [MIM:261540]. PPS is an autosomal recessive disorder characterized by anterior eye-chamber abnormalities, disproportionate short stature, developmental delay, characteristic craniofacial features, cleft lip and/or palate.,function:O-fucosyltransferase that transfers glucose toward fucose with a beta-1,3 linkage. Specifically glucosylates O-linked fucosylglycan on TSP type-1 domains of proteins, thereby contributing to elongation of O-fucosylglycan.,online information:GlycoGene database,pathway:Protein modification; protein glycosylation.,similarity:Belongs to the glycosyltransferase 31 family.,tissue specificity:Widely expressed, with highest levels in testis and uterus.,
      • Subcellular Location:
      • Endoplasmic reticulum membrane ; Single-pass type II membrane protein .
      • Expression:
      • Widely expressed, with highest levels in testis and uterus.
      • Products Images
      • Western Blot analysis of various cells using β-1,3-Gal-TL Polyclonal Antibody diluted at 1:500. Secondary antibody(catalog#:RS0002) was diluted at 1:20000
      • Immunohistochemistry analysis of paraffin-embedded human liver carcinoma tissue, using B3GALTL Antibody. The picture on the right is blocked with the synthesized peptide.
      • Western blot analysis of lysates from HUVEC, MCF-7, Jurkat, and HepG2 cells, using B3GALTL Antibody. The lane on the right is blocked with the synthesized peptide.